Back to search

Article

Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer

2023-09-27

Abstract excerpt

<title>Abstract</title> <p><italic>ARID1A</italic>, an epigenetic tumor suppressor, is the most common gene mutation in clear-cell ovarian cancers (CCOCs). CCOCs are often resistant to standard chemotherapy and lack effective therapies. We hypothesized that <italic>ARID1A </italic>loss would increase CCOC cell dependency on chromatin remodeling and DNA repair pathways for survival. We demonstrate that combining B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d262611d-4cc4-5e62-9238-d7329e4f6b5e
DOI
10.21203/rs.3.rs-3314138/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancerDOI 10.21203/rs.3.rs-3314138/v1
Select a neighboring publication to make it the new centre.